Connection
Kendra Young to Biomarkers
This is a "connection" page, showing publications Kendra Young has written about Biomarkers.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.171 |
|
|
|
-
Zhang YH, Castaldi PJ, Bowler RP, Pratte KA, Kinney GL, Young KA, Rijhwani H, Lutz SM, Hersh CP, Cho MH, Morrow JD, Silverman EK. Proteomic biomarkers of emphysema-predominant and non-emphysema-predominant chronic obstructive pulmonary disease. EBioMedicine. 2025 Jul; 117:105800.
Score: 0.100
-
Young KA, Deane KD, Derber LA, Hughes-Austin JM, Wagner CA, Sokolove J, Weisman MH, Buckner JH, Mikuls TR, O'Dell JR, Keating RM, Gregersen PK, Robinson WH, Holers VM, Norris JM. Relatives without rheumatoid arthritis show reactivity to anti-citrullinated protein/peptide antibodies that are associated with arthritis-related traits: studies of the etiology of rheumatoid arthritis. Arthritis Rheum. 2013 Aug; 65(8):1995-2004.
Score: 0.044
-
Munroe ME, Young K, Lu R, Guthridge JM, Kamen DL, Gilkeson GS, Weisman MH, Ishimori ML, Wallace DJ, Karp DR, Tsokos GC, Keith MP, Harley JB, Norris JM, James JA. Dysregulated soluble immune mediators and lupus-associated autoantibody specificities inform the development of immune indexes that characterise classified SLE transition and SLE disease activity. Lupus Sci Med. 2025 Nov 28; 12(2).
Score: 0.026
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|